Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review

Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review

Aims: Major adverse event (MAE) rates during left ventricular assist device (LVAD) therapy in advanced heart failure (HF) patients are high, and impair quality of life and survival. Prediction and risk stratification of MAEs in order to improve patient selection and thereby outcome during LVAD thera...

Full description

Bibliographic Details
Main Authors: Eva Janssen, J. Wouter Jukema, Saskia L. M. A. Beeres, Martin J. Schalij, Laurens F. Tops
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
left ventricular assist device
circulating biomarkers
natriuretic peptides
adverse events
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.699492/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.699492/full

Similar Items